NuCana PLC (NCNA)
3.13
+0.09
(+2.96%)
USD |
NASDAQ |
Jun 10, 16:00
3.41
+0.28
(+8.95%)
After-Hours: 18:49
NuCana Cash and Short Term Investments (Quarterly): 16.25M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.25M |
December 31, 2023 | 21.94M |
September 30, 2023 | 21.72M |
June 30, 2023 | 31.08M |
March 31, 2023 | 38.40M |
December 31, 2022 | 50.72M |
September 30, 2022 | 56.67M |
June 30, 2022 | 56.43M |
March 31, 2022 | 69.04M |
December 31, 2021 | 81.33M |
September 30, 2021 | 95.37M |
June 30, 2021 | 101.61M |
March 31, 2021 | 108.07M |
December 31, 2020 | 119.05M |
Date | Value |
---|---|
September 30, 2020 | 129.51M |
June 30, 2020 | 58.84M |
March 31, 2020 | 58.88M |
December 31, 2019 | 68.13M |
September 30, 2019 | 71.41M |
June 30, 2019 | 82.59M |
March 31, 2019 | 91.18M |
December 31, 2018 | 97.67M |
September 30, 2018 | 102.08M |
June 30, 2018 | 106.51M |
March 31, 2018 | 114.00M |
December 31, 2017 | 117.17M |
June 30, 2017 | 20.71M |
December 31, 2016 | 24.56M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
16.25M
Minimum
Mar 2024
129.51M
Maximum
Sep 2020
66.85M
Average
63.51M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 143.65M |
Biodexa Pharmaceuticals Plc | 7.606M |
Verona Pharma PLC | 254.88M |
Autolus Therapeutics PLC | 758.53M |
Mereo BioPharma Group PLC | 48.66M |